Cargando…

Real-world treatment practice in patients with advanced melanoma

INTRODUCTION: The treatment outcomes of patients with advanced/metastatic melanoma were poor before the use of new therapeutic options. MATERIAL AND METHODS: A retrospective analysis was conducted among 287 patients with unresectable stage III and stage IV melanoma treated at the Maria Sklodowska-Cu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cybulska-Stopa, Bożena, Piejko, Karolina, Pacholczak, Renata, Domagała-Haduch, Małgorzata, Drosik-Kwaśniewska, Anna, Rolski, Janusz, Wiktor-Mucha, Patrycja, Zemełka, Tomasz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2020
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7403768/ https://www.ncbi.nlm.nih.gov/pubmed/32774137 http://dx.doi.org/10.5114/wo.2020.97607

Ejemplares similares

Overweight is associated with better prognosis in metastatic colorectal cancer patients treated with bevacizumab plus FOLFOX chemotherapy
por: Cybulska-Stopa, Bożena, et al.
Publicado: (2020)

Long-Term Outcomes of Targeted Therapy after First-Line Immunotherapy in BRAF-Mutated Advanced Cutaneous Melanoma Patients—Real-World Evidence
por: Rogala, Paweł, et al.
Publicado: (2022)

Long-Term Real-World Outcomes and Safety of Vemurafenib and Vemurafenib + Cobimetinib Therapy in Patients with BRAF-Mutated Melanoma
por: Piejko, Karolina, et al.
Publicado: (2023)

Immune checkpoint inhibitors therapy in older patients (≥ 70 years) with metastatic melanoma: a multicentre study
por: Cybulska-Stopa, Bożena, et al.
Publicado: (2019)

Systemic treatment in patients with malignant pleural mesothelioma – real life experience
por: Ziółkowska, Barbara, et al.
Publicado: (2022)

Long Term Results and Prognostic Biomarkers for Anti-PD1 Immunotherapy Used after BRAFi/MEKi Combination in Advanced Cutaneous Melanoma Patients
por: Rogala, Paweł, et al.
Publicado: (2022)

Results of systemic treatment of cutaneous melanoma in inoperable stage III and IV
por: Cybulska-Stopa, Bożena, et al.
Publicado: (2013)

Modern Approach to Melanoma Adjuvant Treatment with Anti-PD1 Immune Check Point Inhibitors or BRAF/MEK Targeted Therapy: Multicenter Real-World Report
por: Placzke, Joanna, et al.
Publicado: (2023)

Biomarkers of Trastuzumab-Induced Cardiac Toxicity in HER2- Positive Breast Cancer Patient Population
por: Grela-Wojewoda, Aleksandra, et al.
Publicado: (2022)

Immune-Related Pancytopenia Induced by Anti-PD-1 Therapy – Interrupt or Continue Treatment – The Role of Immunohistochemical Examination
por: Cybulska-Stopa, Bożena, et al.
Publicado: (2019)

Analysis of adverse events of sunitinib in patients treated for advanced renal cell carcinoma
por: Domagała-Haduch, Małgorzata, et al.
Publicado: (2016)

Analysis of the efficacy and tolerability of FOLFIRINOX chemotherapy treatment in patients over 65 years of age with diagnosis of advanced adenocarcinoma of the pancreas
por: Domagała-Haduch, Małgorzata, et al.
Publicado: (2023)

Characteristics of Giant Nodular Melanomas in Special Locations: a Case Series and Review of the Literature
por: Kamińska-Winciorek, Grażyna, et al.
Publicado: (2022)

Stationary random processes associated with point processes
por: Rolski, Tomasz
Publicado: (1981)

Differential Expression of BARD1 Isoforms in Melanoma
por: McDougall, Lorissa I., et al.
Publicado: (2021)

Survival of patients with stage IIIC and IIID melanomas with nodal metastases in the light of new therapies
por: Ziętek, Marcin, et al.
Publicado: (2022)

The Analysis of Trends in Survival for Patients with Melanoma Brain Metastases with Introduction of Novel Therapeutic Options before the Era of Combined Immunotherapy—Multicenter Italian–Polish Report
por: Placzke, Joanna, et al.
Publicado: (2022)

Innate immune checkpoint inhibitor resistance is associated with melanoma sub-types exhibiting invasive and de-differentiated gene expression signatures
por: Hossain, Sultana Mehbuba, et al.
Publicado: (2022)

Principles of prophylactic and therapeutic management of skin toxicity during treatment with checkpoint inhibitors
por: Kamińska-Winciorek, Grażyna, et al.
Publicado: (2019)

Multimodal Treatment of Advanced Mucosal Melanoma in the Era of Modern Immunotherapy
por: Teterycz, Pawel, et al.
Publicado: (2020)

Evaluation of vinorelbine-based chemotherapy as the second or further-line treatment in patients with metastatic breast cancer
por: Cybulska-Stopa, Bożena, et al.
Publicado: (2013)

Neglected malignant neoplasms with cutaneous involvement
por: Kaminska-Winciorek, Grażyna, et al.
Publicado: (2021)

Real-life data of abiraterone acetate and enzalutamide treatment in post-chemotherapy metastatic castration-resistant prostate cancer in Poland
por: Sigorski, Dawid, et al.
Publicado: (2023)

The possibility of lapatinib treatment for breast cancer patients with central nervous system metastases. Case study and literature review
por: Rolski, Janusz, et al.
Publicado: (2013)

Proteins Involved in HER2 Signalling Pathway, Their Relations and Influence on Metastasis-Free Survival in HER2-Positive Breast Cancer Patients Treated with Trastuzumab in Adjuvant Setting
por: Adamczyk, Agnieszka, et al.
Publicado: (2017)

Analysis of efficacy and safety of vismodegib therapy in patients with advanced basal cell carcinoma – real world multicenter cohort study
por: Słowińska, M., et al.
Publicado: (2022)

Relationship between HER2 gene status and selected potential biological features related to trastuzumab resistance and its influence on survival of breast cancer patients undergoing trastuzumab adjuvant treatment
por: Adamczyk, Agnieszka, et al.
Publicado: (2018)

Derivative of the expected supremum of fractional Brownian motion at [Formula: see text]
por: Bisewski, Krzysztof, et al.
Publicado: (2022)

Associations of anthropometric measures on breast cancer risk in pre- and postmenopausal women—a case-control study
por: Pacholczak, Renata, et al.
Publicado: (2016)

Real-world evidence for option value in metastatic melanoma
por: Wong, William B, et al.
Publicado: (2021)

The Current Treatment Trends and Survival Patterns in Melanoma Patients with Positive Sentinel Lymph Node Biopsy (SLNB): A Multicenter Nationwide Study
por: Ziętek, Marcin, et al.
Publicado: (2023)

Invasive bronchial fibroblasts derived from asthmatic patients activate lung cancer A549 cells in vitro
por: Ryszawy, Damian, et al.
Publicado: (2018)

Real World Outcomes of Ipilimumab and Nivolumab in Patients with Metastatic Melanoma
por: Asher, Nethanel, et al.
Publicado: (2020)

Intratumor and Intertumor Heterogeneity in Melanoma
por: Grzywa, Tomasz M., et al.
Publicado: (2017)

Potential Effect of SOX2 on the Cell Cycle of Wharton's Jelly Stem Cells (WJSCs)
por: Świstowska, Małgorzata, et al.
Publicado: (2019)

Real-World Impact of Immune Checkpoint Inhibitors in Metastatic Uveal Melanoma
por: Bol, Kalijn Fredrike, et al.
Publicado: (2019)

Clinical predictors of survival in real world practice in stage IV melanoma
por: Hu, Hsien‐Pang, et al.
Publicado: (2022)

Early Effects of Nivolumab and Ipilimumab Combined Immunotherapy in the Treatment of Metastatic Melanoma in Poland: A Multicenter Experience
por: Pacholczak-Madej, Renata, et al.
Publicado: (2022)

Metal Allergy: State-of-the-Art Mechanisms, Biomarkers, Hypersensitivity to Implants
por: Zemelka-Wiacek, Magdalena
Publicado: (2022)

Serum Allergen-Specific IgE among Pediatric Patients with Primary Immunodeficiency
por: Pieniawska-Śmiech, Karolina, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_41bft95aot46g5vhvfstgo671m